It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
SARS-CoV-2 is the cause of COVID-19. It infects multiple organs including the respiratory tract and gut. Dynamic changes of regional microbiomes in infected adults are largely unknown. Here, we performed longitudinal analyses of throat and anal swabs from 35 COVID-19 and 19 healthy adult controls, as well as 10 non-COVID-19 patients with other diseases, by 16 S rRNA gene sequencing. The results showed a partitioning of the patients into 3-4 categories based on microbial community types (I-IV) in both sites. The bacterial diversity was lower in COVID-19 patients than healthy controls and decreased gradually from community type I to III/IV. Although the dynamic change of microbiome was complex during COVID-19, a synchronous restoration of both the upper respiratory and gut microbiomes from early dysbiosis towards late more diverse status was observed in 6/8 mild COVID-19 adult patients. These findings reveal previously unknown interactions between upper respiratory and gut microbiomes during COVID-19.
Rong Xu, Renfei Lu, Tao Zhang, Qunfu Wu, and colleagues perform a longitudinal analysis of throat and gut microbiomes on adult COVID-19 patients. They find initially lower bacterial diversity in COVID-19 patients, but demonstrate a restoration of microbiome diversity throughout disease progression for patients with mild forms of the disease.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Fudan University, Shanghai Public Health Clinical Center, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443); Pathogen Discovery and Evolution Unit, Institut Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China (GRID:grid.429007.8) (ISNI:0000 0004 0627 2381)
2 Nantong Third Hospital Affiliated to Nantong University, Clinical Laboratory, Nantong, China (GRID:grid.260483.b) (ISNI:0000 0000 9530 8833)
3 Yunnan University, State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, School of Life Sciences, Kunming, China (GRID:grid.440773.3) (ISNI:0000 0000 9342 2456)
4 Medical Laboratory of Taizhou Fourth People’s Hospital, Taizhou, China (GRID:grid.490502.a)
5 Fudan University, Shanghai Public Health Clinical Center, Shanghai, China (GRID:grid.8547.e) (ISNI:0000 0001 0125 2443)